| Serial Number | 79418528 |
| Word Mark | AURIGENE.AI |
| Filing Date | Thursday, April 25, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, June 3, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, June 23, 2026 |
| NOT AVAILABLE | "AI" |
| Indication of Colors claimed | The color(s) dark blue, light blue, yellow, green, white, and black is/are claimed as a feature of the mark. |
| Goods and Services | Recorded and downloadable computer software specifically designed for drug discovery and pharmaceutical drug development using artificial intelligence; Recorded and downloadable computer software specifically designed for in-vitro experimental testing and diagnostics, in-vivo experimental testing and diagnostics, biomedical diagnosis, molecular structure search, intelligent and novel molecule design, compound library screening, new chemical design prediction, aids in early identification of potential failures, for analyzing and developing predictive AI models and generative AI models, for developing, deploying and optimizing computational models, and for computer-aided drug design, for AI-enabled molecular docking and structure-based virtual screenings with computer-aided drug design (CADD) models; recorded and downloadable computer software specifically designed for using predictive and generative AI to develop data science models and for scientific research; recorded and downloadable computer software specifically designed for using predictive and generative AI models and computer-aided drug design (CADD) models to predict how a compound would bind to a target protein; recorded and downloadable computer software specifically designed for using predictive and generative AI models for virtual screening of enumerated target-focused molecules, designing molecules and new chemicals, physics-based and physics-level simulations including molecular dynamics simulations using computational models; recorded and downloadable computer software specifically designed for using predictive and generative AI models to analyze chemical compounds and predict which ones are likely to bind to a disease target; recorded and downloadable computer software specifically designed for using predictive and generative AI models to simulate how a drug moves, bends, and interacts with a target on an atomic level; recorded and downloadable computer software specifically designed for using predictive and generative AI models and computer-aided drug design (CADD) models to predict how a compound would bind to a target protein; all of the foregoing for drug discovery and pharmaceutical drug development using artificial intelligence |
| Description of Mark | The mark consists of the wording "AURIGENE.AI" in black block letters below the stylized letters "AI" in gradient shades of dark blue, light blue, yellow, and green, and within the letters "AI" is a design of stylized thin white lines. |
| Pseudo Mark | AI AURIGENE AI ARTIFICIAL INTELLIGENCE AURIGENE.AI |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 6, 2025 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | AURIGENE PHARMACEUTICAL SERVICES LIMITED |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | IN |
| Event Date | Event Description |
| Thursday, March 6, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Sunday, March 9, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, March 9, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, March 10, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, April 1, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 2, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, June 6, 2025 | REFUSAL PROCESSED BY MPU |
| Friday, June 6, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, June 28, 2025 | REFUSAL PROCESSED BY IB |
| Thursday, August 28, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, August 28, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, August 28, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, August 28, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, October 9, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 9, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, November 30, 2025 | FINAL REFUSAL WRITTEN |
| Sunday, November 30, 2025 | FINAL REFUSAL E-MAILED |
| Sunday, November 30, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, May 27, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, May 27, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 27, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, May 27, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 27, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 17, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |